Patrick Cauntay - Concepedia

Author

Patrick Cauntay

Also Known As

Patrick Cauntay

Publications

404

Citations

H-Index

Concepts

All Affiliations

Patrick Cauntay is an author at Ionis Pharmaceuticals (United States) specializing in gene expression, allergy, and non-coding rna.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	191
2	Natural Sciences	1	1	191
3	Allergy	1	1	191
4	Biochemistry	1	1	191
5	Immunology	1	1	191

Patrick Cauntay

Publications

396

Citations

H-Index

Page 1

	Year	Citations
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts Sebastien A. Burel, Christopher E. Hart, Patrick Cauntay, Nucleic Acids Research ImmunologyMolecular BiologyLong Pre-mrna TranscriptsHigh Affinity ModificationsToxic Lna Asos	2015	191
Comprehensive Structure–Activity Relationship of Triantennary<i>N</i>-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes Thazha P. Prakash, Jinghua Yu, Michael T. Migawa, Journal of Medicinal Chemistry	2016	131
Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response Sebastien A. Burel, Todd Machemer, Frank L. Ragone, Journal of Pharmacology and Experimental Therapeutics	2012	30
The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating <i>In Vivo</i> Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides Suzanne Paz, Jill Hsiao, Patrick Cauntay, Nucleic Acid Therapeutics	2017	28
Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Through TLR9 in Human Burkitt Lymphoma B Bjab Cells Adam J. Pollak, Patrick Cauntay, Todd Machemer, Nucleic Acid Therapeutics	2022	16

Page 1